stockportfolio.pro
RGC vs UHS: Which Stock Is the Better Buy?
Regencell Bioscience Holdings Limited and Universal Health Services, Inc. side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
AI verdict — RGC vs UHS, read from the filings
The stronger business, the cheaper stock, and the risks — synthesised from both companies’ SEC filings, every figure computed not guessed. Not investment advice.
| Regencell Bioscience Holdings Limited (RGC) | Universal Health Services, Inc. (UHS) | |
|---|---|---|
| Market cap | $9.3B | $9.6B |
| Revenue (latest FY) | $0 | $17.36B |
| Net income (latest FY) | $-4.30M | $1.49B |
| Revenue growth (5y CAGR) | — | 8.5% |
| Net margin | — | 8.6% |
| Return on equity | -52.3% | 20.5% |
| P/E ratio | — | 6.6 |
| Dividend yield | — | 0.5% |
| Profitable years (of last 10) | 0 | 10 |
| Positive free cash flow | No | Yes |
See the full RGC vs UHS breakdown
Both companies across 19 years of income statement, balance sheet and cash flow — with ratios, health checks and Ask, the SEC-grounded research assistant. Free, no account needed.
Open RGC's full financials → Open UHS's full financials →More comparisons
Frequently asked questions
Which is bigger, RGC or UHS?
Universal Health Services, Inc. is larger by market capitalization — $9.6B versus $9.3B.
Which grows faster, RGC or UHS?
Five-year growth data is not available for both companies.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.